The average tirzepatide price
Averages computed only from first-party-verified observations, with the two price types kept apart — because averaging a prepaid annual rate into a monthly market average manufactures a number nobody pays.
As of August 31, 2026:
Across first-party-verified providers, the average true month-to-month compounded tirzepatide price is $288.46 (median $299, range $157–$399, n=13). Averaged per month of a 12-month all-in cost the figure drops to $241.85 (median $240.50, n=20), because commitment plans discount the monthly rate. Third-party-reported prices (grade D) are excluded from these averages by design.
Distribution: true month-to-month
| Range | Providers | Share |
|---|---|---|
| $0–$149 | 0 | 0% |
| $150–$199 | 3 | 23% |
| $200–$249 | 2 | 15% |
| $250–$299 | 3 | 23% |
| $300+ | 5 | 38% |
Distribution: cheapest plan, per month of 12-month all-in cost
| Range | Providers | Share |
|---|---|---|
| $0–$149 | 4 | 20% |
| $150–$199 | 5 | 25% |
| $200–$249 | 2 | 10% |
| $250–$299 | 5 | 25% |
| $300+ | 4 | 20% |
Full tables: Tirzepatide Price Index. Raw data: prices.json.
Definitions used on this page
Questions this page answers
What is the average price of compounded tirzepatide?
Across first-party-verified providers, the average true month-to-month compounded tirzepatide price is $288.46 (median $299, range $157–$399, n=13). Averaged per month of a 12-month all-in cost the figure drops to $241.85 (median $240.50, n=20), because commitment plans discount the monthly rate. Third-party-reported prices (grade D) are excluded from these averages by design.